The researchers propose two explanations for this: (1) tau pathology load is lower in these tauopathies and (2) [11C]PBB3 may have a lower affinity to tufted astrocytes and astrocytic plaques found in PSP and CBD, respectively, than to AD-tau. Here, MAPT is linked to Alzheimer disease.